Covidien launches new contrast delivery system for CT
This article was originally published in Clinica
Executive Summary
Covidien has launched its contrast delivery system with radiofrequency identification (RFID) technology in the US. The system could reduce medical errors and increase efficiency in CT imaging, the Hamilton, Bermuda-based firm said. It combines Covidien's Ultraject prefilled contrast media syringes with its Optivantage DH power injector. The RFID technology captures, stores and transmits data between the syringe and the injector, which helps technicians ensure that each patient receives the correct dose of contrast medium. The US FDA granted 510(k) clearance for the system in May.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.